To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
Already a subscriber? Enter your email address below and click "Find" to look up and manage your current contact details and subscription preferences.
FDA approves Adlyxin to treat type 2 diabetes
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2…
Researchers from the Medical Research Council (MRC) Cancer Unit at the University of Cambridge have identified a genetic signature related to metabolism associated with poor patient prognosis. Source link